| INN |
Indication |
Strength |
Dosage |
| Gemcitabin |
Non-Small Cell Lung Cancer: Gemcitabine in combination with cisplatin is indicated as a first line treatment of patients with locally advanced (inoperable Stage IIIA or IIIB) or metastatic (Stage IV) non-small cell lung cancer. Gemcitabine is indicated for the palliative treatment of adult patients with locally advanced or metastatic non-small cell lung cancer. Pancreatic Cancer: Gemcitabine is indicated for the treatment of adult patients with locally advanced or metastatic adenocarcinoma of the pancreas. Gemcitabine is indicated for patients with 5-FU refractory pancreatic cancer. Bladder Cancer:Gemcitabine is indicated for treatment of advanced bladder cancer (muscle invasive Stage IV tumours with or without metastases) in combination with cisplatin therapy. Breast Cancer: Gemcitabine, in combination with paclitaxel, is indicated for the treatment of patients with metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy. Prior chemotherapy should have included an anthracycline, unless clinically contra-indicated. |
200 mg/ 1 g |
Lyophilized |
| Irinotecan |
Irinotecan is indicated for the treatment of patients with advanced colorectal cancer: in combination with 5-fluorouracil and folinic acid in patients without prior chemotherapy for advanced disease, as a single agent in patients who have failed an established 5-fluorouracil containing treatment regimen. |
20 mg/ml in 2 ml and 5 ml |
Solution for infusion |
| Epirubicin |
Wide range of neoplastic conditions, including breast, ovarian, gastric, lung and colorectal carcinomas, malignant lymphomas, leukaemias and multiple myeloma. |
2 mg/ml in 5, 10, 25, 50 and 100 ml |
Solution for injection |
| Carboplatin |
Mono-/Combination therapy.: epithelial ovarian carcinoma, small cell carcinoma of the lung, carcinomas of head and neck area Zervix carcinomas (local recurrent, distal metastasis) |
10 mg/ml in 5, 15 and 45 ml |
Concentrate for Solution for infusion |
| Zoledronic Acid |
Prevention of skeletal related events (pathological fractures, spinal compression, radiation or surgery to bone, or tumour-induced hypercalcaemia) in patients with advanced malignancies involving bone. Treatment of tumour-induced hypercalcaemia (TIH). |
0.8 mg/ml in 5 ml |
Concentrate |
| Voriconnazole |
Treatment of invasive aspergillosis. Treatment of c andi demia in non-neutropenic patients Treatment of fluconazole-resistant serious invasive C andi da infections (including C. krusei). Treatment of serious fungal infections caused by Scedosporium spp. and Fusarium spp. Voriconnazole should be administered primarily to patients with progressive, possibly life-threatening infections. |
200 mg |
Powder for solution for infusion |
| Rocuronium |
Adjunct to general anaesthesia to facilitate tracheal intubation during routine and rapid sequence induction, to provide skeletal muscle relaxation, during surgery. Esmeron is also indicated as an adjunct in the intensive care unit (ICU) to facilitate intubation and mechanical ventilation. |
10 mg/ml in
2.5, 5, and 10 ml |
Solution for injection |
| Cisatracurium |
Utilisation during surgical and other procedures and in intensive care. Can be used as an adjunct to general anaesthesia, or sedation in the Intensive Care Unit (ICU) to relax skeletal muscles, and to facilitate tracheal intubation and mechanical ventilation. |
2 mg/ml in 2.5, 5, 10 and 25 ml |
Solution for injection |
| Remifentanil |
Analgesic agent for use during induction and/or maintenance of general anaesthesia under close supervision. |
1, 2 and 5 mg |
Powder for solution for infusion |
| Ropivacain |
Surgical anaesthesia: Epidural blocks for surgery, including Caesarean section, major nerve blocks, field blocks. Acute pain management: Continuous epidural infusion or intermittent bolus administration during postoperative or labour pain, field blocks, continuous peripheral nerve block via a continuous infusion or intermittent bolus injections, e.g. postoperative pain management. Acute pain management in paediatrics: Caudal epidural block for pre- and post-operative pain management. . |
2, 7.5 and 10 mg/ml in 10 and 20 ml |
Solution for injection and infusion |
